Hunan Er-Kang Pharmaceutical Co., Ltd Stock: price and insider trades · China
尔康制药
Hunan Er-Kang Pharmaceutical Co., Ltd: what insiders have been doing
Insider filings for Hunan Er-Kang Pharmaceutical Co., Ltd are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 22 March 2022. This page will fill in as new trades are disclosed. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 250,000 shares100.0% of flowA股XSHESZSE:173000005380454560
1 of 1 declaration
About Hunan Er-Kang Pharmaceutical Co., Ltd
Erkang Pharmaceutical is a company engaged in the manufacturing of pharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
